Compare PAY & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAY | MMED |
|---|---|---|
| Founded | 2004 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.1B |
| IPO Year | 2021 | 2026 |
| Metric | PAY | MMED |
|---|---|---|
| Price | $27.23 | $11.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $36.29 | $22.56 |
| AVG Volume (30 Days) | 355.3K | ★ 759.1K |
| Earning Date | 05-04-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.57 | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $1,196,507,000.00 | N/A |
| Revenue This Year | $18.60 | $15.99 |
| Revenue Next Year | $18.89 | $10.00 |
| P/E Ratio | $54.92 | ★ N/A |
| Revenue Growth | ★ 37.25 | N/A |
| 52 Week Low | $22.02 | $11.80 |
| 52 Week High | $40.43 | $17.86 |
| Indicator | PAY | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 50.85 | 32.03 |
| Support Level | $23.82 | N/A |
| Resistance Level | $29.88 | $15.80 |
| Average True Range (ATR) | 1.31 | 0.85 |
| MACD | -0.05 | -0.13 |
| Stochastic Oscillator | 8.50 | 1.13 |
Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers through a Software-as-a-Service (SaaS), secure, omni-channel technology platform. The platform integrates with a biller's financial and operational systems to provide secure and flexible processing of payments, including credit cards, debit cards, eChecks, and digital wallets, across multiple channels such as online, mobile, IVR, call centers, chatbots, and voice-based assistants. The company generates the majority of its revenue from payment transaction fees processed through its platform. Geographically, it derives the maximum revenue from the United States.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.